Gout is a type of inflammatory arthritis. The disease is triggered by the crystallization of uric acid within the joints and is associated with hyperuricemia, a condition in which the body either overproduces or under excretes uric acid. Attacks of gout are episodic in nature and although months may pass before the next attack occurs, the pain experienced during an attack can be debilitating. Men are at a higher risk for developing gout and the risk also increases with age, with a mean age at diagnosis for gout in both men and women of 61 years.

1. EpiCast Report: Gout - Epidemiology Forecast to 2023
Gout is a type of inflammatory arthritis. The disease is triggered by the crystallization of uric acid within the joints and is associated with hyperuricemia, a
condition in which the body either overproduces or under excretes uric acid. Attacks of gout are episodic in nature and although months may pass before the next
attack occurs, the pain experienced during an attack can be debilitating. Men are at a higher risk for developing gout and the risk also increases with age, with a
mean age at diagnosis for gout in both men and women of 61 years.
GlobalData epidemiologists forecast an increase in both the diagnosed incident cases and diagnosed prevalent cases of gout in the 6MM, from 1,374,065
diagnosed incident cases in 2013 to 1,649,065 diagnosed incident cases in 2023, at an annual growth rate (AGR) of 2.00%, and 13,750,047 diagnosed prevalent
cases in 2013 to 17,625,944 diagnosed prevalent cases in 2023, at an AGR of 2.82%.
This forecast is supported by ageand sex-specific data obtained from country-specific estimates from peer reviewed journal articles, in which the study
populations were representative of the general population in the respective markets. GlobalData epidemiologists used historical diagnosed incidence and
diagnosed prevalence data which were available for Italy and the UK, along with linear regression methods to forecast the ageand sex-specific diagnosed
incidence and diagnosed prevalence for Italy and the UK through 2023. The forecast provides the ageand sex-specific diagnosed incident cases and diagnosed
prevalent cases of gout in each of the 6MM, with clinically relevant segmentations, which facilitate an in depth understanding of the emerging temporal trends,
and informs strategies to improve the management of the disease. Additionally, GlobalData epidemiologists used the same methodology across the 6MM, which
allows for a meaningful comparison of the forecast diagnosed incident cases and diagnosed prevalent cases of gout across these markets.
Scope
The Gout EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for gout in the six major
markets (6MM) (US, France, Germany, Italy, Spain, and UK). In addition, this report includes a 10-year epidemiological forecast for the diagnosed incident cases
and the diagnosed prevalent cases of gout segmented by sex and age (in five-year age groups beginning at 20 years and ending at =85 years). The diagnosed
prevalent cases are then further segmented by the number of cases of gout flares and tophaceous gout. The gout epidemiology report is written and developed by
Mastersand PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in
the 6MM.
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the global gout market. Quantify patient populations in the global gout market to
improve product design, pricing, and launch plans. Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities
for gout therapeutics in each of the markets covered.
table Of Contents
1 Table Of Contents
1 Table Of Contents 4
1.1 List Of Tables 5
1.2 List Of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors And Comorbidities 8
3.3 Global Trends 10
3.3.1 Us 12
3.3.2 5eu 12
3.4 Forecast Methodology 13
3.4.1 Sources Used 17
3.4.2 Sources Not Used 20
3.4.3 Forecast Assumptions And Methods 22
3.5 Epidemiological Forecast For Gout (2013-2023) 29
3.5.1 Diagnosed Incidence 29
3.5.2 Diagnosed Prevalence 35
3.6 Discussion 43
3.6.1 Epidemiological Forecast Insight 43
3.6.2 Limitations Of The Analysis 44
3.6.3 Strengths Of The Analysis 45
4 Appendix 46
4.1 Bibliography 46
4.2 About The Authors 50
EpiCast Report: Gout - Epidemiology Forecast to 2023

2. 4.2.1 Epidemiologists 50
4.2.2 Reviewers 50
4.2.3 Global Director Of Epidemiology 52
4.2.4 Global Head Of Healthcare 52
4.3 About Globaldata 53
4.4 About Epicast 53
4.5 Disclaimer 54
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
EpiCast Report: Gout - Epidemiology Forecast to 2023